Flightless I Homolog (FLII) Peptide
Quick Overview for Flightless I Homolog (FLII) Peptide (ABIN940147)
Target
Origin
Source
Application
-
-
Peptide Type
- Synthetic
-
Sequence
- LAEDILNTMF DTSYSKQVIN EGEEPENFFW VGIGAQKPYD DDAEYMKHTR
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of FLII antibody,
Alternative Names: FLII control peptide, FLII antibody Blocking Peptide, Anti-FLII Blocking Peptide, Flightless I Homolog Blocking Peptide, FLI Blocking Peptide, FLIL Blocking Peptide, Fli1 Blocking Peptide, MGC39265 Blocking Peptide
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- FLII (Flightless I Homolog (FLII))
-
Background
- FLII is a protein with a gelsolin-like actin binding domain and an N-terminal leucine-rich repeat-protein protein interaction domain. The protein is similar to a Drosophila protein involved in early embryogenesis and the structural organization of indirect flight muscle. This gene is located within the Smith-Magenis syndrome region on chromosome 17.
-
Molecular Weight
- 145 kDa
Target
-